Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Pyridoxine hydrochloride
A A H Pharmaceuticals Ltd
A11HA02
Pyridoxine hydrochloride
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09060204; GTIN: 5025903002352
PACKAGE LEAFLET INFORMATION FOR THE USER PYRIDOXINE 50MG TABLETS PYRIDOXINE HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have further questions, please ask your doctor or pharmacist. - This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours. The name of your medicine is Pyridoxine 50mg Tablets. In the rest of this leaflet it is called Pyridoxine Tablets. IN THIS LEAFLET: 1. What Pyridoxine Tablets are and what they are used for 2. Before you take Pyridoxine Tablets 3. How to take Pyridoxine Tablets 4. Possible side effects 5. How to store Pyridoxine Tablets 6. Further information 1. WHAT PYRIDOXINE TABLETS ARE AND WHAT THEY ARE USED FOR The active ingredient in Pyridoxine Tablets is pyridoxine hydrochloride, which is Vitamin B6. It is used to treat low levels of Vitamin B6 in the body and in the treatment of a condition called idiopathic sideroblastic anaemia where the red cells in the blood do not form properly. Pyridoxine can also be used to treat damage to the nerves (peripheral neuritis) caused by isoniazid, a drug used to treat tuberculosis. 2. BEFORE YOU TAKE PYRIDOXINE TABLETS DO NOT TAKE PYRIDOXINE TABLETS IF: • you are allergic to pyridoxine hydrochloride or any of the other ingredients of Pyridoxine Tablets (see list under ‘What Pyridoxine Tablets contain’ in section 6) If the above statement applies to you, you should not take Pyridoxine Tablets TALK TO YOUR DOCTOR BEFORE TAKING PYRIDOXINE TABLETS IF: • the patient is a child. PYRIDOXINE TABLETS ARE NOT RECOMMENDED FOR CHILDREN. TAKING OTHER MEDICINES Taking another medicine while you are taking Pyridoxine Tablets can affect how it or the other medicine works. Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, including those you may have bought yourself without a prescription. Please check wit Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pyridoxine 50mg Tablets BP 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Pyridoxine Hydrochloride BP 50mg 3. PHARMACEUTICAL FORM Oral tablet 4.1 THERAPEUTIC INDICATIONS Pyridoxine Hydrochloride is used for isoniazid-induced peripheral neuritis, idiopathic sideroblastic anaemia and Vitamin B 6 deficiency states. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _For isoniazid-induced peripheral neuritis _ Adults: Treatment - 50mg three times daily Prophylaxis - Not suitable with this dosage form Children: This presentation is not recommended _For idiopathic sideroblastic anaemia _ Adults: 100 to 400mg daily in divided doses Children: This presentation is not recommended _ _ _For deficiency states _ _ _ Adults: 50 to 150mg daily in divided doses Children: This presentation is not recommended Elderly: Dosage requirements appear to be similar to those for young adults Pyridoxine 50mg Tablets BP 4.3 CONTRAINDICATIONS Hypersensitivity to any of the ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If symptoms persist or worsen, seek medical advice. Do not exceed the stated dose. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Many drugs may alter the metabolism or bioavailability of pyridoxine, including isoniazid, penicillamine and oral contraceptives, _which may increase _ _the requirements for pyridoxine. _Pyridoxine hydrochloride may reduce the effect of levodopa, a drug used in the treatment of Parkinsons Disease unless a dopa decarboxylase inhibitor is also given. 4.6 PREGNANCY AND LACTATION Data on exposed pregnancies indicate no adverse effects of pyridoxine in therapeutic doses on pregnancy or the health of the foetus or newborn child, or during lactation. Animal studies are insufficient with respects to effects on pregnancy, embiyonal/foetal development, parturition or postnatal development. Caution should be exercised when prescribing to pregnant women. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES None known. 4. Read the complete document